Rraynex Pharmaceuticals Pvt. Ltd. | India

Your Indian Partner for Global Pharmaceutical Supply

Q: What does Rraynex manufacture?

Rraynex's catalogue includes pharmaceutical pellets, combination and modified-release pellets, MUPS, pharmaceutical granules, APIs and intermediates. Product availability and specifications are confirmed during enquiry.

Q: Does Rraynex supply pharmaceutical pellets in bulk?

Yes. International pharmaceutical companies can enquire about bulk pellet supply, including enteric-coated, sustained-release, immediate-release, delayed-release and combination products.

Q: Where are Rraynex's facilities located?

The brochure identifies a pellets, granules and MUPS facility in Boisar, Tarapur MIDC, Maharashtra, and a nutraceutical premix facility in Hyderabad, Telangana.

Q: What capacities are available?

The brochure lists 145 MT/month pharmaceutical pellet capacity, 75 MT/month pharmaceutical granule capacity and 30 MT/month dedicated nutraceutical pellet capacity. These figures are separate capacities.

Q: What documentation can Rraynex support?

Depending on the product and project, Rraynex can discuss DMF open and closed part support, VQM support, TSE/BSE/MSDS documentation, stability data, batch documentation and quality information.

Q: Which international markets is Rraynex developing?

CIS, Latin America and other Rest of World markets are identified as international market-development regions. A specific destination, registration route and supply status should be confirmed with the commercial team.

Specialised pellets, granules, MUPS and nutraceutical formulations for pharmaceutical companies, formulators and supply partners.

Explore manufacturing capabilities Discuss your requirements

Built for B2B collaboration

A focused manufacturing partner for international buyers

Rraynex is an India-based pharmaceutical manufacturing and supply partner focused on specialised pellets, granules, MUPS and nutraceutical formulations. The company combines dedicated production capabilities with technical documentation and quality-focused operations for formulation and sourcing teams.

145 MT/monthPharmaceutical pellet capacitySource: company brochure

75 MT/monthPharmaceutical granule capacitySource: company brochure

30 MT/monthDedicated nutraceutical pellet capacitySource: company brochure

100+Pharmaceutical companies served across IndiaSource: company brochure

25+ yearsLeadership experience in pellets and APIsSource: company brochure

Why international buyers consider Rraynex

Capabilities aligned to pharmaceutical supply programmes

Specialised manufacturing

Pellets, granules and MUPS are central to the company’s manufacturing focus.

Dedicated capacity

Separate capacity figures help buyers assess the relevant product platform without combining unlike operations.

Portfolio breadth

Pellets, granules, APIs, intermediates and nutraceutical solutions support multiple sourcing conversations.

Quality-focused operations

Raw material evaluation, process control, finished product testing and batch documentation are part of the quality discussion.

Technical documentation

DMF, VQM, TSE/BSE/MSDS and stability data support can be discussed according to product and project.

Long-term partnerships

Rraynex is positioned for collaborative business development with pharmaceutical companies and formulation teams.

India manufacturing context

Sourcing from an established pharmaceutical manufacturing ecosystem

India’s pharmaceutical ecosystem brings together formulation manufacturing, APIs, intermediates, technical services and export infrastructure. For international procurement teams, the right partner is defined by the fit between product capability, documentation, quality requirements, volume and destination regulations. Rraynex’s role is to develop those conversations around its documented capabilities.

Product platforms

Pharmaceutical products for formulation partners

Pharmaceutical pellets

Enteric-coated, sustained-release, immediate-release, delayed-release and combination pellet platforms for formulation partners.

Browse pellet products

MUPS and granules

MUPS pellets and pharmaceutical granules, including direct-compression formats where confirmed by the product catalogue.

Browse granule products

APIs and intermediates

Selected APIs and advanced intermediates listed in the current Rraynex catalogue for pharmaceutical manufacturing programmes.

Browse APIs

Nutraceutical solutions

Nutraceutical premix and blend pellets and supplements for business-to-business formulation and supply discussions.

Discuss a requirement

Manufacturing footprint

Two locations, distinct production roles

Boisar, Tarapur MIDC, Maharashtra

Pellets, granules and MUPS facility. Pharmaceutical pellet capacity: 145 MT/month. Pharmaceutical granule capacity: 75 MT/month.

Hyderabad, Telangana

Nutraceutical premix facility. Dedicated nutraceutical pellet capacity: 30 MT/month.

Quality and documentation

Information buyers can use to assess fit

Rraynex discusses quality assurance, process control, documentation, traceability and stability information as part of the commercial and technical enquiry process. Support may include DMF open and closed parts, VQM, TSE/BSE/MSDS and product documentation, subject to the product and project.

Certification scope and validity should be confirmed for the relevant facility and product before procurement or regulatory use. EU-GMP is identified as a future target for 2027, not an existing certification.

Raw material evaluation
In-process controls
Finished product testing
Batch documentation and traceability
Stability data
Technical and regulatory documentation

International market development

Connecting markets. Building pharmaceutical partnerships.

Rraynex identifies CIS, Latin America and other Rest of World markets as areas for international business development. These are target regions, not a claim that every country shown is an active export destination.

Explore the worldwide page →

CISLatin AmericaRest of World

Leadership and expertise

Experience that understands specialised pharmaceutical supply

Mr. Pramod Pawar

Leadership experience of 25+ years in pellets and APIs, according to the company brochure.

Mr. Nishit Gupta

Promoter and director involved in guiding Rraynex’s pharmaceutical business.

Ms. Raina D. Desai

Promoter and director contributing to the company’s leadership and governance.

International buyer FAQ

Questions procurement teams ask

What does Rraynex manufacture?

Does Rraynex supply pharmaceutical pellets in bulk?

Where are Rraynex's facilities located?

What capacities are available?

What documentation can Rraynex support?

Which international markets is Rraynex developing?

Start a conversation

Let’s build a reliable pharmaceutical supply partnership.

Share your product, specification, volume and market requirements with the Rraynex team.

Send an international enquiry